RenovoRx Patent Issued

US Patent Trademark Office Seal

Menlo Park, CA (October 28, 2014) – RenovoRx, a leading developer of innovative solutions for the isolation of blood flow and delivery of fluids to selected sites in the vascular system, today announced that the United States Patent and Trademark Office has issued U.S. patent application number 12/958,711 entitled “Devices, Methods and Kits for the Delivery of Therapeutic Material.” The issuance of U.S. Patent Number 8,821,476 covers the company’s slidable, double balloon catheter for delivering therapies to visceral and peripheral vasculature.

“This patent further strengthens our intellectual property portfolio,” said Ramtin Agah, RenovoRx Co-Founder. “We are pleased to receive an issued patent that protects our technology as we prepare to launch the RenovoCath™ RC120 to the market and as we continue product development.”


Previous Post
RenovoRx Board Names Shaun R. Bagai as CEO
Next Post
RenovoCath™ RC120 Receives FDA 510(k) Clearance